Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBUPROFEN\PSEUDOEPHEDRINE vs ICATIBANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBUPROFEN\PSEUDOEPHEDRINE vs ICATIBANT: Safety Overview

Metric IBUPROFEN\PSEUDOEPHEDRINE ICATIBANT
Total FAERS Reports 785 5,363
Deaths Reported 5 234
Death Rate 0.6% 4.4%
Hospitalizations 103 2,451
Average Patient Age 46.4 yrs 46.3 yrs
% Female Patients 69.1% 75.0%
FDA Approval Date N/A Aug 14, 2023
Manufacturer N/A Alembic Pharmaceuticals Inc.
Route N/A SUBCUTANEOUS
Marketing Status N/A Prescription